Skip to content

R3 71332440Recalls & reported problems

Smith & Nephew, Inc. · R3 ANTEVERTED LINER TRIAL 36MM INNER DIAMETER X OUTER DIAMETER 50MM +4 · Class 2

Data updated Oct 16, 2026 from official FDA records · Editorial policy

Adverse event reports
2
Deaths reported
0
Injuries reported
0
Recalls naming it
0

Summary

The FDA's MAUDE database contains 2 adverse event reports that list this exact device (DI 00885556491645), received between May 25, 2022 and Aug 28, 2022 — classified as 2 malfunctions.

The most frequently reported specific device problem is “Break” (2 reports).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.

Most reported problems

Device problems

  • Break2

Patient problems

  • No Clinical Signs, Symptoms or Conditions2

Recent adverse event reports

The 2 most recent of 2 reports, in the reporter's own words as published by the FDA.

  • MalfunctionAug 28, 2022Break; Break

    IT WAS REPORTED THAT THE R3 ANTE LNR TRIAL 36MM X 50MM +4 WAS CRACK, AND IT ENDED UP BREAKING WHEN TOOK FURTHER ACTION INTO INVESTIGATING. SINCE IT WAS NOTICED DURING A FIELD INSPECTION, NO PATIENT WAS INVOLVED.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 15307954 ↗
  • MalfunctionMay 25, 2022Break; Break

    IT WAS REPORTED THAT AN R3 ANTEVERTED LINER TRIAL 36MM INNER DIAMETER X OUTER DIAMETER 50MM +4 WAS FOUND TO BE BROKEN. AS THIS WAS NOTICED UPON INSPECTION AFTER CLEANING, THERE WAS NOT PATIENT INVOLVEMENT.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 14493699 ↗

Other Prosthesis, hip, semi-constrained, uncemented, metal/polymer, porous devices

All Prosthesis, hip, semi-constrained, uncemented, metal/polymer, porous devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page